Marinus Pharmaceuticals - 53 Year Dividend History | MRNS
Historical dividend payout and yield for Marinus Pharmaceuticals (MRNS) since 1971. The current TTM dividend payout for Marinus Pharmaceuticals (MRNS) as of November 20, 2024 is $0.00. The current dividend yield for Marinus Pharmaceuticals as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.017B |
$0.031B |
|
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on developing and commercializing therapeutics for the treatment of epilepsy and other targeted neurological, behavioral and psychiatric disorders. The Company offers Ganaxolone which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures. Marinus Pharmaceuticals, Inc. is headquartered in New Haven, Connecticut.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
